Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

Physician burnout and intentions to reduce clinical effort or leave one’s institution are results of poor control over specific aspects of work.

The US CDC has taken down multiple health-related websites and datasets, including those on HIV, LGBTQ health and more.

The traditional Chinese practice of qigong can effectively alleviate chronic low back pain, according to study findings.

There has been a large decrease in antidepressant use during pregnancy and no corresponding increase in psychotherapy claims.

Lifetime history of heavy cannabis use is associated with lower brain activation on working memory tasks among young adults.

Despite persistent racial and ethnic disparities in postoperative sepsis and septic shock risk, there is no evidence of inequity in regard to failure-to-rescue (FTR) rates for either condition. These ...

The shutdown of HHS web pages pertaining to HIV, LGBTQ+ health, and adolescent health raises questions about the future of infectious disease monitoring and research on these topics.

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

As a bird flu outbreak escalates across the US, the Trump administration has paused the release of key public health studies, stalling research that could provide insight into how the virus spreads to ...